Approach to Chest Pain

1. THE PATHOPHYSIOLOGY

• Neurobiological Mechanisms of Chest Pain:

• Visceral Afferent Convergence & Referred Pain: Visceral nociceptive afferents from the heart, pericardium, aorta, and esophagus travel via sympathetic trunks to common dorsal root ganglia and second-order spinothalamic neurons in the upper thoracic spinal cord (\(T_1\text{--}T_5\)). Because these second-order neurons also receive somatic sensory input from the chest wall, neck, jaw, and arms, the cortex cannot precisely localize the origin of visceral pain. This produces the classic poorly localized, diffuse "chest discomfort" (pressure, tightness, heaviness, or squeezing) that frequently radiates to the left arm, right arm, bilateral arms, neck, jaw, or epigastrium.

• Somatic Afferent Innervation: Somatic nociceptors in the parietal pleura, chest wall, outer adventitia, and parietal pericardium travel via intercostal and phrenic nerves. Direct stimulation of these fibers generates sharp, well-localized, pleuritic (inspiration-aggravated), or position-dependent pain.

• Physical & Anatomical Mechanisms of Critical Disease:

• Myocardial Ischemia & Infarction (ACS): Acute disruption or erosion of an atherosclerotic coronary plaque triggers platelet activation, aggregation, and arterial thrombosis. The resulting mismatch between coronary arterial blood flow and myocardial oxygen demand leads to cellular hypoxia, anaerobic metabolism, lactic acidosis, myocardial necrosis, and release of cardiac biomarkers (troponin).

• Aortic Shear Stress & Intimal Tear (Aortic Dissection): High systemic vascular resistance and physical arterial shear stress (\(dP/dt\)) trigger a primary intimal tear in the thoracic aorta, creating a false lumen within the aortic media. Propagation of the false lumen can compress branch vessels (causing cerebral, spinal, or limb malperfusion), disrupt the aortic root (causing acute aortic regurgitation), extend into the coronary ostia (precipitating STEMI), or rupture into the pericardium/pleural space.

• Pulmonary Vascular Occlusion (PE): Embolization of thrombi into the pulmonary arterial bed increases pulmonary vascular resistance, elevating right ventricular (RV) afterload. Severe RV dilation and myocardial strain cause septal shift, reducing left ventricular filling, impairing cardiac output, and causing ventilation-perfusion (\(V/Q\)) mismatch with refractory hypoxemia.

• Intrapleural Air Trapping (Tension Pneumothorax): A one-way valvular pleural defect permits air entry into the pleural space during inspiration without escape during expiration. Accumulating intrapleural pressure causes complete lung collapse, mediastinal shift, compression of the vena cava, loss of venous return (preload), and obstructive shock.

• Barogenic Esophageal Perforation (Boerhaave Syndrome): Transmural esophageal rupture (typically post-forceful emesis) releases acidic gastric contents, digestive enzymes, and oral flora into the mediastinum. This induces rapid, severe chemical mediastinitis, bacterial tissue necrosis, subcutaneous/mediastinal emphysema (Hamman's crunch), and overwhelming septic shock.

• Pericardial Fluid Accumulation (Tamponade): Fluid or blood accumulating rapidly within the fixed non-compliant pericardial sac exceeds critical filling volume. Compressive pressure impairs diastolic ventricular filling, collapses right-sided heart chambers, reduces stroke volume, and precipitates obstructive shock.

2. THE CRITICAL DDx MATRIX

                    EMERGENCY CHEST PAIN RISK STRATIFICATION
                                       │
         ┌─────────────────────────────┴─────────────────────────────┐
         ▼                                                           ▼
  [ KILL IN MINUTES ]                                         [ KILL IN HOURS ]
(Immediate Resuscitative, Shock,                            (Progressive Ischemic, Infectious,
 Vascular & Mechanical Crises)                               Inflammatory & Structural Disasters)
 ── Tension Pneumothorax                                    ── Non-ST Elevation ACS (NSTEMI / Unstable Angina)
 ── Cardiac Tamponade                                       ── Esophageal Rupture (Boerhaave Syndrome)
 ── Massive Pulmonary Embolism                              ── Acute Myopericarditis / Unstable Effusion
 ── Acute STEMI / Occlusion MI w/ Shock                     ── Severe Pneumonia / Empyema / Sepsis
 ── Acute Type A Thoracic Aortic Dissection                  ── Perforated Peptic Ulcer / Abdominal Disaster

Kill in Minutes (Immediate Resuscitative, Shock, Vascular & Mechanical Crises)

• Tension Pneumothorax: Clinical emergency featuring sudden unilateral chest pain, severe dyspnea, hypotension, unilateral absent breath sounds, hyperresonance to percussion, tracheal deviation, and obstructive shock.
• Cardiac Tamponade: Pericardial fluid accumulation causing Beck's triad (hypotension, elevated JVD, muffled heart sounds), pulsus paradoxus (\(>10\text{ mmHg}\) SBP drop on inspiration), low voltage/electrical alternans on ECG, and obstructive shock.
• Massive Pulmonary Embolism: Acute occlusion of pulmonary vasculature leading to syncope, acute RV strain on ECG/POCUS, severe hypoxemia, and obstructive or cardiogenic shock.
• Acute STEMI / Occlusion MI with Cardiogenic Shock: Acute ST-elevations or equivalent occlusion patterns, severe left/right ventricular pump failure, diffuse crackles (pulmonary edema), severe hypotension, and circulatory collapse.
• Acute Type A Thoracic Aortic Dissection: Abrupt, maximal-at-onset "tearing" or "ripping" chest/back pain, pulse deficits, asymmetric limb blood pressures, acute aortic regurgitation murmur, or coronary ostial occlusion causing secondary STEMI.

Kill in Hours (Progressive Ischemic, Infectious, Inflammatory & Structural Disasters)

• Non-ST Elevation ACS (NSTEMI / Unstable Angina): Crescendo exertional or rest angina, dynamic ST-segment depressions, T-wave inversions, or elevated high-sensitivity troponin levels threatening impending complete vessel occlusion.
• Esophageal Rupture (Boerhaave Syndrome) & Mediastinitis: Sudden severe substernal chest/back pain following forceful vomiting, subcutaneous emphysema in the neck/chest, Hamman's crunch, left-sided pleural effusion, and rapid septic breakdown.
• Acute Myopericarditis / Unstable Effusion: Constant, sharp, retrosternal pleuritic chest pain relieved by sitting forward, friction rub, diffuse concave ST-elevations with PR-segment depressions, and troponin elevation.
• Severe Pneumonia / Empyema / Sepsis: Focal pleuritic chest pain, fever, productive cough, localized bronchial breath sounds or rales, and systemic inflammatory toxicity.
• Perforated Peptic Ulcer / Acute Abdominal Disasters: Epigastric pain radiating into the chest, severe peritoneal signs, free air under the diaphragm on CXR, and septic or hemorrhagic collapse.

3. THE DIAGNOSTIC ENGINE

                     EMERGENCY CHEST PAIN DIAGNOSTIC ALGORITHM
                                         │
           [ Doorway Assessment: ABCs, Telemetry, IV Access, SpO2 Monitor ]
                                         │
         ┌───────────────────────────────┴───────────────────────────────┐
         ▼                                                               ▼
  [ Rapid Parallel Track: First 10 Minutes ]                   [ Unstable / Crashing Patient ]
  - Obtain & review 12-lead ECG (<10 min)                                │
  - Screen for STEMI / Occlusion MI patterns                             ▼
  - Assess vitals & breath sounds                              [ Bedside POCUS (RUSH Protocol) ]
         │                                                     - Check for Tamponade (RA/RV collapse)
         ▼                                                     - Check for RV Strain / D-sign (PE)
  [ Diagnostic & Risk Stratification Path ]                    - Check for Lung Sliding (Pneumothorax)
  - Perform POCUS (Cardiac / LUS / Aorta)                      - Check Aortic Root Diameter
  - Order High-Sensitivity Troponin (hs-cTn)                             │
  - Apply Clinical Decision Pathway (HEART / EDACS)                      ▼
         │                                                     [ Immediate Resuscitative Action ]
         ├───────────────────────────────┬───────────────────────────────┤
         ▼                               ▼                               ▼
  [ STEMI / ACS ]              [ Suspected Dissection ]          [ Suspected PE ]
  - Activate Primary PCI        - CTA Chest & Aorta               - CTPA / V/Q Scan
  - Aspirin 162-325mg           - HR <60 bpm & SBP <120           - Anticoagulation /
  - P2Y12 Inhibitor               (Esmolol + Vasodilator)           Thrombolysis

Step 1: Doorway Assessment & Parallel Track (First 10 Minutes)

• Continuous Monitoring & Access: Immediately place all chest pain patients on cardiac telemetry, obtain continuous pulse oximetry, and establish IV access.
• 12-Lead ECG Within 10 Minutes: Obtain and review a 12-lead ECG within 10 minutes of presentation. Repeat ECGs every 15–30 minutes for recurrent pain, dynamic changes, or changes in clinical status.
• Unilateral Absent Breath Sounds + Shock: Immediately diagnose Tension Pneumothorax clinically and perform needle or finger thoracostomy prior to chest radiography or other imaging.

Step 2: Emergency Bedside Point-of-Care Ultrasound (POCUS)

POCUS provides immediate diagnostic differentiation in the unstable or undifferentiated chest pain patient:

• Pericardial View: Identifies pericardial effusion and tamponade mechanics (right atrial systolic collapse, right ventricular diastolic collapse, plethoric non-collapsible IVC).
• Right Ventricular Strain: Identifies RV dilation, RV free-wall hypokinesis, or septal flattening ("D-shaped" LV) indicating acute massive Pulmonary Embolism.
• Lung Ultrasound: Identifies loss of lung sliding and "lung point" (Pneumothorax), or multiple bilateral B-lines (Acute Decompensated Heart Failure / Pulmonary Edema).
• Aortic View: Evaluates aortic root enlargement or an intra-aortic intimal flap supporting Aortic Dissection.

Step 3: High-Sensitivity Biomarkers & Clinical Decision Pathways (CDPs)

• High-Sensitivity Cardiac Troponin (hs-cTn): Preferred biomarker strategy applied through validated 0/1-hour or 0/2-hour Accelerated Diagnostic Protocols.
• Risk Stratification Pathways: Apply evidence-based tools (HEART Score/Pathway, EDACS) to integrate History, ECG, Age, Risk Factors, and Troponin. A HEART Score \(\le 3\) with negative serial troponins identifies low-risk patients (\(<1%\) 30-day MACE) appropriate for discharge.
• D-Dimer Protocol: Indicated strictly in patients with low-to-intermediate pre-test probability for PE (e.g., Wells \(\le 4\) or PERC). Critical Pitfall: D-dimer has an unacceptable false-negative rate (\(12%\text{--}23%\)) in high pre-test probability patients; high-probability cases must proceed directly to CTPA without D-dimer testing.

Step 4: Targeted Imaging Modalities

• Chest Radiography (CXR): Evaluates for widened mediastinum (\(61%\)) or abnormal aortic contour (\(50%\)) in dissection, pneumothorax, pulmonary edema, pneumonia, or pneumomediastinum/pleural effusion in esophageal rupture.
• CT Angiography (CTA):
• CTA Chest & Aorta: Gold-standard study of choice for Aortic Dissection.
• CT Pulmonary Angiography (CTPA): Gold-standard study of choice for Pulmonary Embolism.
• Thoracic CT with IV and Water-Soluble Oral Contrast: Preferred imaging test for suspected Esophageal Rupture.

4. EMPIRIC MANAGEMENT

First-Line Resuscitative & Ischemic Stabilization

• Oxygen Therapy: Administer supplemental oxygen ONLY if hypoxemic (target \(SpO_2 \ge 92%\text{--}94%\)). Routine oxygen in normoxic patients is not recommended.
• Aspirin: Administer 162 to 325 mg PO (chewed) immediately for any suspected ACS presentation.
• Nitroglycerin: Administer Sublingual Nitroglycerin 0.4 mg every 5 minutes (up to 3 doses) for ongoing anginal pain, followed by IV infusion for persistent symptoms.
• Strict Contraindications:

        1.  Hypotension (\\(SBP < 90\text{ mmHg}\\)).
        2.  Inferior MI with Right Ventricular Infarction (V4R ST-elevation) due to severe preload dependence.
        3.  Recent use of Phosphodiesterase-5 inhibitors (Sildenafil/Vardenafil within 24 hours or Tadalafil within 48 hours) due to risk of fatal refractory hypotension.

• P2Y12 Antiplatelet & Anticoagulation: Administer Clopidogrel (300–600 mg PO) or Ticagrelor (180 mg PO) along with parenteral anticoagulation (Unfractionated Heparin, Enoxaparin, or Fondaparinux) per ACS protocol.

Disease-Specific Emergency Stabilization

                  TARGETED EMPIRIC EMERGENCY PHARMACOTHERAPY
                                      │
         ┌────────────────────────────┼────────────────────────────┐
         ▼                            ▼                            ▼
  [ STEMI / Revascularization ]   [ Aortic Dissection ]        [ Massive PE Shock ]
 - Primary PCI (Door-to-balloon  - Anti-Impulse Therapy:      - Systemic Thrombolysis:
   <90 min)                       1. IV Esmolol / Labetalol      Alteplase (tPA) 100mg IV
 - Fibrinolysis (if PCI delay       to HR <60 bpm                or Embolectomy
   >120 min)                     2. Add Vasodilator (Nicardipine) - IV UFH Infusion
 - Aspirin + P2Y12 Inhibitor        to SBP <120 mmHg

• STEMI Revascularization: Emergent activation of the Cardiac Catheterization Laboratory for Primary PCI (goal door-to-balloon time \(<90\) minutes). If PCI cannot be delivered within 120 minutes, administer IV Fibrinolytic therapy (Tenecteplase/Alteplase) if no contraindications exist.
• Thoracic Aortic Dissection Anti-Impulse Protocol:
• Step 1: Administer short-acting IV Beta-blockers (Esmolol infusion or Labetalol IV) to suppress cardiac contractility (\(dP/dt\)) and target Heart Rate \(< 60\text{ bpm}\).
• Step 2: ONLY after heart rate is control below 60 bpm, add titratable vasodilators (Nicardipine or Nitroprusside IV) to target Systolic BP \(< 120\text{ mmHg}\). (Vasodilators given without prior beta-blockade trigger reflex tachycardia and increase aortic shear forces). Immediate cardiothoracic surgery consult.
• Massive Pulmonary Embolism with Shock:
• Administer Systemic Thrombolytic Therapy (Alteplase 100 mg IV over 2 hours) or arrange catheter-directed/surgical embolectomy for PE presenting with persistent hypotension (\(SBP < 90\text{ mmHg}\)) or obstructive shock. Initiate IV Unfractionated Heparin.
• Esophageal Rupture (Boerhaave Syndrome):
• NPO status, aggressive crystalloid volume resuscitation, IV Proton Pump Inhibitor (Pantoprazole 80 mg IV bolus), empiric broad-spectrum parenteral antibiotics + antifungal coverage (e.g., Cefepime + Metronidazole + Fluconazole/Vancomycin), and immediate thoracic surgery consultation.

5. THE DISPOSITION TRAPS

• The "Normal Initial ECG & Troponin" False Reassurance Trap:
• Cognitive Error: Discharging a patient with ongoing or crescendo chest discomfort because their baseline 12-lead ECG is normal and the initial single troponin is negative.
• Clinical Reality: Up to 20% of patients with acute MI present with an initial normal ECG, and at least 1% to 6% of chest pain patients with a normal baseline ECG are ultimately diagnosed with NSTEMI. A single baseline troponin drawn \(<3\) hours from pain onset has reduced sensitivity. Serial ECGs and serial high-sensitivity troponin testing via a validated CDP are mandatory before considering discharge.
• The "Nitroglycerin or Antacid Diagnostic Response" Myth:
• Cognitive Error: Concluding that chest pain is non-cardiac or gastrointestinal because it abates following sublingual nitroglycerin or an oral "GI cocktail" (antacid/viscous lidocaine).
• Clinical Reality: Nitroglycerin relaxes smooth muscle and relieves esophageal spasm just as effectively as anginal ischemia. Furthermore, up to 18% to 45% of patients with confirmed ACS report significant pain relief from antacid therapy. Response to therapeutic trials CANNOT safely differentiate cardiac from non-cardiac pain.
• The "Reproducible Chest Wall Tenderness" Pitfall:
• Cognitive Error: Ruling out ACS in a patient presenting with acute chest pain because the pain is reproduced by palpation over the sternum or costochondral joints.
• Clinical Reality: Chest wall tenderness is reproducibly present in up to 15% of patients with confirmed acute MI. While palpation tenderness lowers pre-test probability, it CANNOT be used as an isolated finding to exclude ACS.
• The "Framingham Risk Factor Over-Reliance" Trap:
• Cognitive Error: Dismissing ACS in a young patient (\(<40\) years) because they lack traditional Framingham cardiovascular risk factors (hypertension, hyperlipidemia, diabetes).
• Clinical Reality: Framingham risk factors were derived to predict 10-year population CAD development, NOT to predict the acute likelihood of ACS during an emergency visit. Patients without traditional risk factors remain vulnerable to acute plaque rupture, thrombosis, or cocaine/amphetamine-induced vasospasm and infarction.
• The "Aortic Dissection STEMI Mask" Catastrophe:
• Cognitive Error: Immediately administering heavy anticoagulation, antiplatelet therapy, or IV fibrinolytics to a patient with inferior ST-segment elevations on ECG without evaluating for acute Type A aortic dissection when clinical red flags exist.
• Clinical Reality: Approximately 1 in 1000 STEMIs is caused by a Type A aortic dissection extending proximally into the coronary ostia (most commonly the Right Coronary Artery). Administering antithrombotics or fibrinolytics in the setting of acute dissection triggers catastrophic aortic rupture and death. Always screen for ripping back pain, pulse deficits, or a new aortic regurgitation murmur prior to thrombolysis.